← Back to Analyst Consensus 
VOR Buy
Vor Biopharma Inc.
Current Price —
Implied Upside —
Analysts 13
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 21, 2026 | William Blair | initiate | — → Outperform | — | 48% |
| Aug 12, 2026 | Wedbush | maintain | Neutral → Neutral | — | 58% |
| May 18, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 14, 2026 | Wedbush | maintain | Neutral → Neutral | — | 58% |
| Apr 15, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 31, 2026 | Wedbush | maintain | Neutral → Neutral | — | 58% |
| Mar 30, 2026 | Jefferies | initiate | — → Buy | — | 52% |
| Mar 19, 2026 | Wells Fargo | initiate | — → Overweight | — | 54% |
| Jan 9, 2026 | Citigroup | initiate | — → Buy | $50 | 54% |
| Dec 19, 2025 | JP Morgan | maintain | Overweight → Overweight | $40 | 54% |
| Dec 17, 2025 | TD Cowen | initiate | — → Buy | $0 | 54% |
| Dec 9, 2025 | JP Morgan | initiate | — → Overweight | $43 | 54% |
| Nov 14, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $32 | 44% |
| Oct 29, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $55 | 44% |
| Oct 15, 2025 | Baird | upgrade | Neutral → Outperform | $64 | 55% |
| Aug 14, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $3 | 44% |
| Jun 30, 2025 | HC Wainwright & Co. | upgrade | Neutral → Buy | $3 | 44% |
| Jun 27, 2025 | Baird | maintain | Neutral → Neutral | $1 | 55% |
| Jun 26, 2025 | Wedbush | reiterate | Neutral → Neutral | $0.4 | 58% |
| May 9, 2025 | JMP Securities | downgrade | Market Outperform → Market Perform | $6 | 53% |
| May 9, 2025 | HC Wainwright & Co. | downgrade | Buy → Neutral | $0 | 44% |
| Mar 21, 2025 | Oppenheimer | reiterate | Outperform → Outperform | $8 | 52% |
| Mar 21, 2025 | Stifel | maintain | Buy → Buy | $5 | 53% |
| Mar 21, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $13 | 44% |
| Dec 10, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $17.5 | 44% |
| Dec 10, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $12 | 53% |
| Nov 8, 2024 | Baird | maintain | Outperform → Outperform | $14 | 55% |
| Nov 8, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $17.5 | 44% |
| Sep 6, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $12 | 53% |
| Sep 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $17.5 | 44% |
| Aug 14, 2024 | Barclays | maintain | Overweight → Overweight | $3 | 53% |
| May 13, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $12 | 53% |
| May 13, 2024 | Oppenheimer | reiterate | Outperform → Outperform | $10 | 52% |
| May 10, 2024 | Wedbush | reiterate | Outperform → Outperform | $11 | 58% |
| Apr 23, 2024 | Wedbush | reiterate | Outperform → Outperform | $11 | 58% |
| Mar 22, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $12 | 53% |
| Mar 21, 2024 | Stifel | maintain | Buy → Buy | $12 | 53% |
| Mar 21, 2024 | Wedbush | reiterate | Outperform → Outperform | $11 | 58% |
| Mar 21, 2024 | Oppenheimer | reiterate | Outperform → Outperform | $15 | 52% |
| Mar 21, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $17.5 | 44% |
| Jan 18, 2024 | Wedbush | reiterate | Outperform → Outperform | $11 | 58% |
| Aug 14, 2023 | JMP Securities | reiterate | Market Outperform → Market Outperform | $12 | 53% |
| Aug 11, 2023 | Wedbush | maintain | Outperform → Outperform | $11 | 58% |
| Aug 11, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $17.5 | 44% |
| Jun 12, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $17.5 | 44% |
| May 16, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $17.5 | 44% |
| May 16, 2023 | JonesTrading | initiate | — → Buy | $18 | 75% |
| May 15, 2023 | Oppenheimer | reiterate | Outperform → Outperform | $18 | 52% |
| May 12, 2023 | Wedbush | reiterate | Outperform → Outperform | $18 | 58% |
| Mar 24, 2023 | Truist Securities | maintain | — → Buy | $16 | 54% |
Price Target Trend
May 7, 2026 Oct 26, 2026
EPS Estimates
+1q —
0q —
+1y —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days